Advances in neuro-oncology imaging

KJ Langen, N Galldiks, E Hattingen… - Nature Reviews …, 2017 - nature.com
Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key …

The 18 kDa translocator protein, microglia and neuroinflammation

GJ Liu, RJ Middleton, CR Hatty, WWY Kam… - Brain …, 2014 - Wiley Online Library
The 18 kDa translocator protein (TSPO), previously known as the peripheral
benzodiazepine receptor, is expressed in the injured brain. It has become known as an …

Noninvasive molecular imaging of neuroinflammation

AH Jacobs, B Tavitian… - Journal of Cerebral …, 2012 - journals.sagepub.com
Inflammation is a highly dynamic and complex adaptive process to preserve and restore
tissue homeostasis. Originally viewed as an immune-privileged organ, the central nervous …

[HTML][HTML] Cellular sources and regional variations in the expression of the neuroinflammatory marker translocator protein (TSPO) in the normal brain

C Betlazar, M Harrison-Brown, RJ Middleton… - International Journal of …, 2018 - mdpi.com
The inducible expression of the mitochondrial translocator protein 18 kDa (TSPO) by
activated microglia is a prominent, regular feature of acute and chronic-progressive brain …

[HTML][HTML] The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy

N Galldiks, I Law, WB Pope, J Arbizu, KJ Langen - NeuroImage: Clinical, 2017 - Elsevier
Routine diagnostics and treatment monitoring of brain tumors is usually based on contrast-
enhanced MRI. However, the capacity of conventional MRI to differentiate tumor tissue from …

[HTML][HTML] Constructing the immune signature of schizophrenia for clinical use and research; an integrative review translating descriptives into diagnostics

RA Kroken, IE Sommer, VM Steen, I Dieset… - Frontiers in …, 2019 - frontiersin.org
Schizophrenia is considered a syndrome comprised by several disease phenotypes,
covering a range of underlying pathologies. One of these disease mechanisms seems to …

TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

NL Albert, M Unterrainer, DF Fleischmann… - European journal of …, 2017 - Springer
Objective The 18-kDa mitochondrial translocator protein (TSPO) was reported to be
upregulated in gliomas. 18 F-GE-180 is a novel 3rd generation TSPO receptor ligand with …

[HTML][HTML] A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma

J Bolcaen, J Kleynhans, S Nair, J Verhoeven… - Theranostics, 2021 - ncbi.nlm.nih.gov
Despite numerous clinical trials and pre-clinical developments, the treatment of glioblastoma
(GB) remains a challenge. The current survival rate of GB averages one year, even with an …

Imaging of the glioma microenvironment by TSPO PET

B Zinnhardt, F Roncaroli, C Foray, E Agushi… - European journal of …, 2021 - Springer
Gliomas are highly dynamic and heterogeneous tumours of the central nervous system
(CNS). They constitute the most common neoplasm of the CNS and the second most …

Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study

M Unterrainer, DF Fleischmann, C Diekmann… - European journal of …, 2019 - Springer
Background PET represents a valuable tool for glioma imaging. In addition to amino acid
tracers such as 18 F-FET, PET targeting the 18-kDa mitochondrial translocator-protein …